PT  - JOURNAL ARTICLE
AU  - Sean Coulborn
AU  - Chris Taylor
AU  - Lorina Naci
AU  - Adrian M. Owen
AU  - Davinia Fernández-Espejo
TI  - Disruptions in effective connectivity within and between default mode network and anterior forebrain mesocircuit in prolonged disorders of consciousness
AID  - 10.1101/2021.04.10.21255204
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.10.21255204
4099  - http://medrxiv.org/content/early/2021/04/17/2021.04.10.21255204.short
4100  - http://medrxiv.org/content/early/2021/04/17/2021.04.10.21255204.full
AB  - Recent research indicates prolonged disorders of consciousness (PDOC) result from structural and functional impairments to key cortical and subcortical networks including the default mode network (DMN) and the anterior forebrain mesocircuit (AFM). However, the specific mechanisms which underpin such impairments remain unknown. It is known that disruptions in the striatal-pallidal pathway can result in the over inhibition of the thalamus and lack of excitation to the cortex that characterises PDOC. Here, we used spectral dynamic causal modelling and parametric empirical Bayes on rs-fMRI data to assess whether DMN changes in PDOC are caused by disruptions in the AFM.PDOC patients displayed overall reduced coupling within the AFM, and specifically, decreased self-inhibition of the striatum paired with reduced coupling from striatum to thalamus. This led to loss of inhibition from AFM to DMN, mostly driven by posterior areas including the precuneus and inferior parietal cortex. In turn, the DMN showed disruptions in self-inhibition of the precuneus and medial prefrontal cortex.Our results provide support for the anterior mesocircuit model at the subcortical level but highlight an inhibitory role for the AFM over the DMN, which is disrupted in PDOC.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Medical Research Council (MRC) via studentship to SC, Data collection was supported by the Canadian Institutes of Health Research (AMO, DF-E), and the Canada Excellence Research Chairs Program (AMO). DF-E. is further supported by an MRC-NIRG.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The University of Western Ontario Health Sciences Research Ethics Board (London, Ontario, Canada) provided ethical approval for the study. All healthy volunteers provided informed written consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymised data may be made available upon reasonable request